Novo Nordisk Strengthens Semaglutide Defense with Real-World Data as Pipeline Awaits Judgment
Novo Nordisk unveils real-world evidence challenging Eli Lilly’s tirzepatide, advances CagriSema and Zenagamtide, and slashes Wegovy price for…
Novo Nordisk’s MASH Data Strengthens Semaglutide’s Case as Buyback and Earnings Add Context
Novo Nordisk presents Phase 3 ESSENCE subgroup data for semaglutide in MASH, showing efficacy across underrepresented groups. Revenue…
Novo Nordisk Secures Dual EU Backing for Wegovy as Semaglutide Liver Data Strengthens Pipeline
Novo Nordisk gains CHMP backing for Wegovy 7.2mg pen and oral tablet, presents promising MASH data, and announces…
The Evening Sun | Phoebus Masonic Lodge Of New Berlin Strengthens Community Ties With Donation And Youth Support
NEW BERLIN – The Phoebus Masonic Lodge of New Berlin continues to demonstrate its commitment to community service…
Virtune strengthens its Nordic presence by appointing a Country Manager for Finland
Stockholm, April 1, 2026 – Virtune, a leading Swedish and regulated digital asset manager in the Nordics, is…